Nicotine patch shows benefits in mild cognitive impairment

February, 2012

A pilot study suggests that wearing a nicotine patch may help improve memory loss in older adults with mild cognitive impairment.

The study involved 74 non-smokers with amnestic MCI (average age 76), of whom half were given a nicotine patch of 15 mg a day for six months and half received a placebo. Cognitive tests were given at the start of the study and again after three and six months.

After 6 months of treatment, the nicotine-treated group showed significant improvement in attention, memory, speed of processing and consistency of processing. For example, the nicotine-treated group regained 46% of normal performance for age on long-term memory, whereas the placebo group worsened by 26%.

Nicotine is an interesting drug, in that, while predominantly harmful, it can have positive effects if the dose is just right, and if the person’s cognitive state is at a particular level (slipping below their normal state, but not too far below). Too much nicotine will make things worse, so it’s important not to self-medicate.

Nicotine has been shown to improve cognitive performance in smokers who have stopped smoking and previous short-term studies with nicotine have shown attention and memory improvement in people with Alzheimer's disease. Nicotine receptors in the brain are reduced in Alzheimer’s brains.

Because the dose is so crucial, and the effects so dependent on brain state (including, one assumes, whether the person has been a smoker or not), more research is needed before this can be used as a treatment.

http://www.eurekalert.org/pub_releases/2012-01/vumc-sfn010912.php
http://www.eurekalert.org/pub_releases/2012-01/aaon-ctn010312.php

Reference:

[2736] Newhouse, P., Kellar K., Aisen P., White H., Wesnes K., Coderre E., et al.
(2012). Nicotine treatment of mild cognitive impairment.
Neurology. 78(2), 91 - 101.

seniors

nicotine

MCI

Alzheimers

Related News

Teenage physical activity reduces risk of cognitive impairment later

A large longitudinal study, comparing physical activity at teenage, age 30, age 50, and late life against cognition of 9,344 women, has revealed that women who are physically active at any point have a lower risk of cognitive impairment in late-life compared to those who are inactive, but teenage

Abdominal fat at middle age associated with greater risk of dementia

A study involving 733 participants from the Framingham Heart Study Offspring Cohort (average age 60) provides more evidence that excess abdominal fat places otherwise healthy, middle-aged people at greater risk for dementia later in life.

Looking after a spouse with dementia greatly increases your own risk of dementia

A 12-year study involving 1,221 married couples ages 65 or older (part of the Cache County (Utah) Memory Study) has revealed that husbands or wives who care for spouses with dementia are six times more likely to develop Alzheimer’s themselves than those whose spouses don't have it.

Alzheimer's expressed differently in carriers and noncarriers of the Alzheimer’s gene

A comprehensive study reveals how the ‘Alzheimer's gene’ (APOE ε4) affects the nature of the disease. It is not simply that those with the gene variant tend to be more impaired (in terms of both memory loss and brain damage) than those without.

Animal studies indicate caffeine may slow dementia and cognitive decline but human studies less conclusive

A special supplement in the Journal of Alzheimer's Disease focuses on the effects of caffeine on dementia and age-related cognitive decline. Here are the highlights:

Extending lifespan has mixed effects on learning and memory

Studies on the roundworm C. elegans have revealed that the molecules required for learning and memory are the same from C.

Promise of drug therapy for age-related memory loss

Although research has so far been confined to mouse studies, researchers are optimistic about the promise of histone deacetylase inhibitors in reversing age-related memory loss — both normal decline, and the far more dramatic loss produced by Alzheimer’s.

Test of implantable cardioverter defibrillator linked to cognitive problems

An implantable cardioverter defibrillator (ICD) is a small electronic device that monitors and regulates heartbeat, and many have been implanted in patients — an estimated 114,000 in the U.S. in 2006.

Smoking may counteract benefit of moderate drinking on stroke risk

A 12-year study following the drinking and smoking habits of 22,524 people aged 39-79 has found that in non-smokers, people who consumed moderate amounts of alcohol were 37% less likely to develop stroke than non-drinkers. This association was not found among smokers.

Why older adults remember the good times better

An imaging study reveals why older adults are better at remembering positive events.

Pages